Thomas Woiwode, Director at Audentes Therapeutics, Inc. (BOLD), bought 1,116,477 shares at $15.00 ($525K) on 2016-07-25, disclosed to the SEC on 2016-07-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,081,477 | $0 | 0.0% |
| 2 | $15.00 | 219 | $3K | 0.6% |
| 3 | $15.00 | 34,781 | $522K | 99.4% |
| Total | $0.47 avg | 1,116,477 | $525K | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |